IOVA logo

Iovance Biotherapeutics, Inc. (IOVA) Operating Profit

Annual Operating Profit:

-$395.28M+$65.28M(+14.17%)
December 31, 2024

Summary

  • As of today, IOVA annual operating income is -$395.28 million, with the most recent change of +$65.28 million (+14.17%) on December 31, 2024.
  • During the last 3 years, IOVA annual operating profit has fallen by -$52.58 million (-15.34%).
  • IOVA annual operating profit is now -2501659.49% below its all-time high of -$15.80 thousand, reached on December 31, 2009.

Performance

IOVA Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAincome statement metrics

Quarterly Operating Profit:

-$89.76M+$24.02M(+21.11%)
September 30, 2025

Summary

  • As of today, IOVA quarterly operating income is -$89.76 million, with the most recent change of +$24.02 million (+21.11%) on September 30, 2025.
  • Over the past year, IOVA quarterly operating profit has dropped by -$692.00 thousand (-0.78%).
  • IOVA quarterly operating profit is now -3902421.74% below its all-time high of -$2300.00, reached on December 31, 2009.

Performance

IOVA Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAincome statement metrics

TTM Operating Profit:

-$411.33M-$692.00K(-0.17%)
September 30, 2025

Summary

  • As of today, IOVA TTM operating income is -$411.33 million, with the most recent change of -$692.00 thousand (-0.17%) on September 30, 2025.
  • Over the past year, IOVA TTM operating profit has increased by +$18.63 million (+4.33%).
  • IOVA TTM operating profit is now -2619829.94% below its all-time high of -$15.70 thousand, reached on December 31, 2009.

Performance

IOVA TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

IOVA Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+14.2%-0.8%+4.3%
3Y3 Years-15.3%+10.6%-5.1%
5Y5 Years-91.1%-52.2%-59.1%

IOVA Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-15.3%+14.2%-3.7%+26.0%-5.1%+12.0%
5Y5-Year-91.1%+14.2%-52.2%+26.0%-59.1%+12.0%
All-TimeAll-Time>-9999.0%+14.2%>-9999.0%+26.0%>-9999.0%+12.0%

IOVA Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
-$89.76M(+21.1%)
-$411.33M(-0.2%)
Jun 2025
-
-$113.77M(+6.1%)
-$410.64M(-3.0%)
Mar 2025
-
-$121.22M(-40.0%)
-$398.78M(-0.9%)
Dec 2024
-$395.28M(+14.2%)
-$86.58M(+2.8%)
-$395.28M(+8.1%)
Sep 2024
-
-$89.07M(+12.6%)
-$429.96M(+6.4%)
Jun 2024
-
-$101.91M(+13.4%)
-$459.25M(+1.7%)
Mar 2024
-
-$117.72M(+2.9%)
-$467.43M(-1.5%)
Dec 2023
-$460.56M(-15.5%)
-$121.26M(-2.4%)
-$460.56M(-3.2%)
Sep 2023
-
-$118.36M(-7.5%)
-$446.34M(-4.2%)
Jun 2023
-
-$110.09M(+0.7%)
-$428.37M(-2.5%)
Mar 2023
-
-$110.86M(-3.6%)
-$418.02M(-4.8%)
Dec 2022
-$398.88M(-16.4%)
-$107.04M(-6.6%)
-$398.88M(-1.9%)
Sep 2022
-
-$100.39M(-0.7%)
-$391.31M(-3.8%)
Jun 2022
-
-$99.73M(-8.7%)
-$377.15M(-5.1%)
Mar 2022
-
-$91.71M(+7.8%)
-$358.85M(-4.7%)
Dec 2021
-$342.70M(-30.8%)
-$99.47M(-15.3%)
-$342.70M(-9.9%)
Sep 2021
-
-$86.24M(-5.9%)
-$311.77M(-9.6%)
Jun 2021
-
-$81.43M(-7.7%)
-$284.50M(-6.7%)
Mar 2021
-
-$75.57M(-10.3%)
-$266.70M(-1.8%)
Dec 2020
-$261.94M(-26.6%)
-$68.53M(-16.2%)
-$261.94M(-1.3%)
Sep 2020
-
-$58.97M(+7.3%)
-$258.51M(-2.9%)
Jun 2020
-
-$63.63M(+10.1%)
-$251.16M(-5.7%)
Mar 2020
-
-$70.81M(-8.8%)
-$237.70M(-14.9%)
Dec 2019
-$206.87M(-61.3%)
-$65.11M(-26.2%)
-$206.87M(-17.1%)
Sep 2019
-
-$51.61M(-2.9%)
-$176.71M(-10.3%)
Jun 2019
-
-$50.16M(-25.5%)
-$160.15M(-13.3%)
Mar 2019
-
-$39.99M(-14.4%)
-$141.37M(-10.2%)
Dec 2018
-$128.26M(-38.1%)
-$34.94M(+0.3%)
-$128.26M(-7.4%)
Sep 2018
-
-$35.06M(-11.7%)
-$119.39M(-11.9%)
Jun 2018
-
-$31.38M(-16.7%)
-$106.67M(-7.9%)
Mar 2018
-
-$26.88M(-3.1%)
-$98.87M(-6.5%)
Dec 2017
-$92.88M(-73.2%)
-$26.07M(-16.7%)
-$92.88M(-12.3%)
Sep 2017
-
-$22.34M(+5.2%)
-$82.73M(-4.2%)
Jun 2017
-
-$23.58M(-12.9%)
-$79.36M(-17.6%)
Mar 2017
-
-$20.88M(-31.1%)
-$67.51M(-25.9%)
DateAnnualQuarterlyTTM
Dec 2016
-$53.64M(-92.5%)
-$15.92M(+16.1%)
-$53.64M(-14.7%)
Sep 2016
-
-$18.98M(-61.8%)
-$46.75M(-32.0%)
Jun 2016
-
-$11.73M(-67.3%)
-$35.41M(-17.5%)
Mar 2016
-
-$7.01M(+22.4%)
-$30.13M(-6.0%)
Dec 2015
-$27.86M(-131.4%)
-$9.03M(-18.2%)
-$28.42M(-17.2%)
Sep 2015
-
-$7.64M(-18.7%)
-$24.25M(-24.9%)
Jun 2015
-
-$6.44M(-21.6%)
-$19.41M(-28.7%)
Mar 2015
-
-$5.30M(-8.8%)
-$15.08M(-25.2%)
Dec 2014
-$12.04M(+46.8%)
-$4.87M(-73.7%)
-$12.04M(-38.2%)
Sep 2014
-
-$2.80M(-32.8%)
-$8.71M(+43.1%)
Jun 2014
-
-$2.11M(+6.6%)
-$15.32M(-7.6%)
Mar 2014
-
-$2.26M(-46.6%)
-$14.24M(-12.3%)
Dec 2013
-$22.64M(-178.4%)
-$1.54M(+83.6%)
-$12.68M(+1.4%)
Sep 2013
-
-$9.41M(-814.1%)
-$12.87M(-153.0%)
Jun 2013
-
-$1.03M(-46.0%)
-$5.08M(+10.8%)
Mar 2013
-
-$704.90K(+59.1%)
-$5.70M(+29.9%)
Dec 2012
-$8.13M(+61.4%)
-$1.72M(-5.8%)
-$8.13M(+22.1%)
Sep 2012
-
-$1.63M(+1.1%)
-$10.43M(+28.6%)
Jun 2012
-
-$1.65M(+47.5%)
-$14.62M(+37.9%)
Mar 2012
-
-$3.14M(+22.1%)
-$23.54M(-11.8%)
Dec 2011
-$21.06M(-2482.6%)
-$4.02M(+30.8%)
-$21.06M(-20.1%)
Sep 2011
-
-$5.81M(+44.9%)
-$17.53M(-47.5%)
Jun 2011
-
-$10.56M(-1504.6%)
-$11.88M(-745.2%)
Mar 2011
-
-$658.20K(-32.7%)
-$1.41M(-72.4%)
Dec 2010
-$815.40K(-5060.8%)
-$496.10K(-197.1%)
-$815.40K(-153.5%)
Sep 2010
-
-$167.00K(-97.4%)
-$321.60K(-103.4%)
Jun 2010
-
-$84.60K(-25.0%)
-$158.10K(-105.9%)
Mar 2010
-
-$67.70K(-2843.5%)
-$76.80K(-389.2%)
Dec 2009
-$15.80K(+72.3%)
-$2300.00(+34.3%)
-$15.70K(+43.3%)
Sep 2009
-
-$3500.00(-6.1%)
-$27.70K(-3.7%)
Jun 2009
-
-$3300.00(+50.0%)
-$26.70K(+30.5%)
Mar 2009
-
-$6600.00(+53.8%)
-$38.40K(+32.7%)
Dec 2008
-$57.10K
-$14.30K(-472.0%)
-$57.10K(-33.4%)
Sep 2008
-
-$2500.00(+83.3%)
-$42.80K(-6.2%)
Jun 2008
-
-$15.00K(+40.7%)
-$40.30K(-59.3%)
Mar 2008
-
-$25.30K
-$25.30K

FAQ

  • What is Iovance Biotherapeutics, Inc. annual operating income?
  • What is the all-time high annual operating profit for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. annual operating profit year-on-year change?
  • What is Iovance Biotherapeutics, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Iovance Biotherapeutics, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. TTM operating profit year-on-year change?

What is Iovance Biotherapeutics, Inc. annual operating income?

The current annual operating profit of IOVA is -$395.28M

What is the all-time high annual operating profit for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high annual operating income is -$15.80K

What is Iovance Biotherapeutics, Inc. annual operating profit year-on-year change?

Over the past year, IOVA annual operating income has changed by +$65.28M (+14.17%)

What is Iovance Biotherapeutics, Inc. quarterly operating income?

The current quarterly operating profit of IOVA is -$89.76M

What is the all-time high quarterly operating profit for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high quarterly operating income is -$2300.00

What is Iovance Biotherapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, IOVA quarterly operating income has changed by -$692.00K (-0.78%)

What is Iovance Biotherapeutics, Inc. TTM operating income?

The current TTM operating profit of IOVA is -$411.33M

What is the all-time high TTM operating profit for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high TTM operating income is -$15.70K

What is Iovance Biotherapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, IOVA TTM operating income has changed by +$18.63M (+4.33%)
On this page